Mostrar el registro sencillo del ítem

Artículo

dc.creatorCasadesús Pursals, Josepes
dc.creatorUrdaneta Páez, Verónica Carolinaes
dc.date.accessioned2017-11-14T17:09:20Z
dc.date.available2017-11-14T17:09:20Z
dc.date.issued2017
dc.identifier.citationCasadesús Pursals, J. y Urdaneta Páez, V.C. (2017). Interactions between Bacteria and Bile Salts in the Gastrointestinal and Hepatobiliary Tracts. Frontiers in Medicine, 4 (163), 1-13.
dc.identifier.issn2296-858Xes
dc.identifier.urihttp://hdl.handle.net/11441/66028
dc.description.abstractBile salts and bacteria have intricate relationships. The composition of the intestinal pool of bile salts is shaped by bacterial metabolism. In turn, bile salts play a role in intestinal homeostasis by controlling the size and the composition of the intestinal microbiota. As a consequence, alteration of the microbiome–bile salt homeostasis can play a role in hepatic and gastrointestinal pathological conditions. Intestinal bacteria use bile salts as environmental signals and in certain cases as nutrients and electron acceptors. However, bile salts are antibacterial compounds that disrupt bacterial membranes, denature proteins, chelate iron and calcium, cause oxidative damage to DNA, and control the expression of eukaryotic genes involved in host defense and immunity. Bacterial species adapted to the mammalian gut are able to endure the antibacterial activities of bile salts by multiple physiological adjustments that include remodeling of the cell envelope and activation of efflux systems and stress responses. Resistance to bile salts permits that certain bile-resistant pathogens can colonize the hepatobiliary tract, and an outstanding example is the chronic infection of the gall bladder by Salmonella enterica. A better understanding of the interactions between bacteria and bile salts may inspire novel therapeutic strategies for gastrointestinal and hepatobiliary diseases that involve microbiome alteration, as well as novel schemes against bacterial infectionses
dc.description.sponsorshipEspaña, MINECO BIO2013-44220-Res
dc.formatapplication/pdfes
dc.language.isoenges
dc.publisherFrontiers Mediaes
dc.relation.ispartofFrontiers in Medicine, 4 (163), 1-13.
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectbile saltses
dc.subjectintestinal microbiomees
dc.subjectgene regulationes
dc.subjectresistance to bilees
dc.subjectSalmonellaes
dc.subjectchronic infectiones
dc.titleInteractions between Bacteria and Bile Salts in the Gastrointestinal and Hepatobiliary Tractses
dc.typeinfo:eu-repo/semantics/articlees
dcterms.identifierhttps://ror.org/03yxnpp24
dc.type.versioninfo:eu-repo/semantics/publishedVersiones
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses
dc.contributor.affiliationUniversidad de Sevilla. Departamento de Genéticaes
dc.relation.projectIDBIO2013-44220-Res
dc.relation.publisherversionhttp://dx.doi.org/10.3389/fmed.2017.00163es
dc.identifier.doi10.3389/fmed.2017.00163es
idus.format.extent13 p.es
dc.journaltitleFrontiers in Medicinees
dc.publication.volumen4es
dc.publication.issue163es
dc.publication.initialPage1es
dc.publication.endPage13es
dc.contributor.funderMinisterio de Economía y Competitividad (MINECO). España

FicherosTamañoFormatoVerDescripción
pub2fmed-04-00163.pdf1.430MbIcon   [PDF] Ver/Abrir  

Este registro aparece en las siguientes colecciones

Mostrar el registro sencillo del ítem

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como: Attribution-NonCommercial-NoDerivatives 4.0 Internacional